Go Deep
Milestone Scientific Inc.
Milestone Scientific Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,374 | -8.2 | 8.53 | 0.18 | 30.94 |
| Oct 2026 | 17,378 | -8.2 | 8.52 | 0.18 | 30.92 |
| Oct 2026 | 17,037 | -8.3 | 8.69 | 0.18 | 31.57 |
| Oct 2026 | 16,927 | -8.5 | 8.83 | 0.18 | 32.06 |
| Oct 2026 | 17,536 | -7.8 | 8.09 | 0.18 | 29.32 |
| Oct 2026 | 17,504 | -7.8 | 8.13 | 0.18 | 29.40 |
| Oct 2026 | 17,645 | -7.6 | 7.96 | 0.18 | 28.91 |
Milestone Scientific Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,841,038.0 | 2,162,033.0 | 2,057,979.0 | 2,360,117.0 |
| Net Profit | -1,059,332.0 | -839,853.0 | -1,090,561.0 | -1,153,959.0 |
| EPS | -0.0 | -0.0 | — | -0.0 |
Milestone Scientific Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 8,973,982.0 | 8,629,928.0 | 9,827,444.0 | 8,805,906.0 | — |
| Net Profit | -5,722,216.0 | -4,713,597.0 | -6,929,104.0 | -8,706,131.0 | — |
| EPS | -0.1 | -0.1 | -0.1 | -0.1 | — |
Milestone Scientific Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 7,806,429.0 | 9,797,072.0 | 11,371,512.0 | 13,702,086.0 | — |
| Total Liabilities | 4,993,806.0 | 3,964,372.0 | 3,359,000.0 | 3,695,652.0 | — |
| Total Equity | 2,812,623.0 | 5,832,700.0 | 8,012,512.0 | 10,225,710.0 | — |
Owes vs Owns
Milestone Scientific Inc. owed $0.58 for every $1 it owned in Jun 2026, up from $0.27 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.58× | 0.64× | 0.40× | 0.30× | 0.27× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Milestone Scientific Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 14.3%Receivables 9.0%Inventory 48.4%Fixed assets (tangible) 2.9%Intangible assets 1.0%Other assets 24.4%
How it's funded — Dec 2025
Short-term debt 2.0%Long-term debt 10.2%Payables 18.3%Other liabilities 33.4%Shareholders' equity 36.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1.1 | 3.3 | 6.0 | 8.7 |
| Receivables | 0.7 | 0.5 | 0.3 | 0.7 |
| Inventory | 3.8 | 3.7 | 2.6 | 1.8 |
| Fixed assets (tangible) | 0.2 | 0.3 | 0.4 | 0.5 |
| Intangible assets | 0.1 | 0.1 | 0.2 | 0.2 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.9 | 1.9 | 1.9 | 1.8 |
| Liabilities & equity | ||||
| Short-term debt | 0.2 | 0.1 | 0.1 | 0.1 |
| Long-term debt | 0.8 | 0.2 | 0.3 | 0.4 |
| Payables | 1.4 | 1.0 | 0.7 | 1.1 |
| Other liabilities | 2.6 | 2.6 | 2.3 | 2.1 |
| Shareholders' equity | 2.8 | 5.8 | 8.0 | 10.0 |
| Net tangible assets | 2.7 | 5.7 | 7.8 | 10.0 |
Milestone Scientific Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -2,916,627.0 | -2,919,875.0 | -5,326,129.0 | -6,031,996.0 | — |
| Investing Activities | -15,124.0 | 2,966,449.0 | -2,972,172.0 | -8,527.0 | — |
| Financing Activities | 786,335.0 | 233,771.0 | 2,560,735.0 | -8,544.0 | — |